Perfusing and ventilating the patient's lungs during bypass ameliorates the increase in extravascular thermal volume after coronary bypass grafting

Annals of Thoracic Surgery

Volumn 76, Issue 2, 2003, Pages 516-521

  Massoudy, Parwis ^a   Piotrowski, Jarowit A ^a   Van De Wal, Henry C J M ^a   Giebler, Reiner ^a   Marggraf, Günter ^a   Peters, Jürgen ^a   Jakob, Heinz G ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTHELIN 1; INTERLEUKIN 8; THROMBOXANE B2;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY SURGERY; DYE DILUTION CURVE; EXTRACORPOREAL CIRCULATION; EXTRAVASCULAR THERMAL VOLUME; FEMALE; HEART INDEX; HEMATOCRIT; HEMODYNAMIC PARAMETERS; HUMAN; INFLAMMATION; LUNG ARTERY PRESSURE; LUNG EDEMA; LUNG FLUID; LUNG PERFUSION; LUNG VENTILATION; MALE; PRIORITY JOURNAL; PROGNOSIS; SYSTEMIC VASCULAR RESISTANCE;

AGED; AGED, 80 AND OVER; CARDIOPULMONARY BYPASS; CASE-CONTROL STUDIES; CORONARY ARTERY BYPASS; CORONARY DISEASE; EXTRACORPOREAL CIRCULATION; EXTRAVASCULAR LUNG WATER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; OXYGEN; PROBABILITY; PROSPECTIVE STUDIES; PULMONARY GAS EXCHANGE; REFERENCE VALUES; RESPIRATION, ARTIFICIAL; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0042158346     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)00347-3     Document Type: Article

References (20)

1. Massoudy P, Zahler S, Becker BF, Braun SL, Barankay A, Meisner H. Evidence for inflammatory responses of the lungs during coronary artery bypass grafting with cardiopulmonary bypass. Chest 2001;119:31-6.
2. De Vroege R, Rutten PM, Kalkman C, et al. Biocompatibility of three different membrane oxygenators: effects on complement, neutrophil and monocyte activation. Perfusion 1997;12:369-75.
3. Massoudy P, Zahler S, Becker BF, et al. Significant leukocyte and platelet retention during pulmonary passage after declamping of the aorta in CABG patients. Eur J Med Res 1999;4:178-82.
4. Schlensak C, Doenst T, Beyersdorf F. Lung ischemia during cardiopulmonary bypass. Ann Thorac Surg 2000;70:337-8.
5. Drew CE, Keen G, Benazon DB. Profound hypothermia. Lancet 1957;2:1323-9.
6. Richter JA, Meisner H, Tassani P, Barankay A, Dietrich W, Braun SL. Drew-Anderson technique attenuates SIRS and improves respiratory function after CABG. Ann Thorac Surg 2000;69:77-83.
7. Massoudy P, Zahler S, Tassani P, et al. Reduction of proinflammatory cytokine levels and cellular adhesion in CABG procedures with separated pulmonary and systemic extracorporal circulation without an oxygenator. Eur J Cardiothorac Surg 2000;17:729-36.
8. Suzuki T, Fukuda T, Ito T, Inoue Y, Cho Y, Kashima Y. Continuous pulmonary perfusion during cardiopulmonary bypass prevents lung injury in infants. Ann Thorac Surg 2000;69:602-6.
9. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-44.
10. Dupuis J, Stewart DJ, Cernacek P, Gosselin G. Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 1996;94:1578-84.
11. Shafique T, Sellke FW, Thurer RL, Weintraub RM, Johnson RG. Cardiopulmonary bypass and pulmonary thromboxane generation. Ann Thorac Surg 1993;55:724-8.
12. Eising GP, Niemeyer M, Günther T, et al. Does a hyperoncotic cardiopulmonary bypass prime affect extravascular lung water and cardiopulmonary function in patients undergoing coronary artery bypass surgery? Eur J Cardiothorac Surg 2001;20:282-9.
13. 2 saturation and a-v differences. In: Lewis FR, Pfeiffer UJ, eds. Practical applications of fiberoptics in critical care monitoring. Berlin: Springer, 1990:114-25.
14. Sturm JA. Development and significance of lung water measurement in clinical and experimental practice. In: Lewis FR, Pfeiffer UJ, eds. Practical applications of fiberoptics in critical care monitoring. Berlin: Springer, 1990:129-39.
15. Honore PM, Jaquet LM, Beale RJ, et al. Effects of normothermia versus hypothermia on extravascular lung water and serum cytokines during cardiopulmonary bypass: a randomized, controlled trial. Crit Care Med 2001;29:1903-9.
16. Erez E, Erman A, Snir E, et al. Thromboxane production in human lung during cardiopulmonary bypass: beneficial effect of aspirin? Ann Thorac Surg 1998;65:101-6.
17. Friedman M, Selke FW, Wang SY, Weintraub RM, Johnson RG. Parameters of pulmonary injury after total or partial cardiopulmonary bypass. Circulation 1994;90:II-262-8.
18. Mathieu P, Dupuis J, Carrier M, et al. Pulmonary metabolism of endothelin-1 during on-pump and beating heart coronary artery bypass operations. J Thorac Cardiovasc Surg 2001;121:1137-42.
19. Matheis G, Haak T, Beyersdorf F, Baretti R, Polywka C, Winkelmann BR. Circulating endothelin in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg 1995;9:269-74.
20. Effros RM. Lung water measurements with the mean transit time approach. J Appl Physiol 1985;59:673-85.